Search & Analyze
Popular Searches
JFL Life Sciences Ltd.
Healthcare₹10.85
CMP₹10.85
Mkt Cap₹36 Cr
P/E5.59
P/B0.78
ROE11.09%
52W High₹0.00
52W Low₹0.00
Customise metrics bar
Stock DNA
Key Ratios
P/E Ratio
5.59
P/B Ratio
0.78
EV/EBITDA
4.76
Price/Sales
0.27
Dividend Yield (%)
0.00
EPS (TTM ₹)
1.94
Book Value (₹)
13.90
ROE (%)
11.09
ROCE (%)
15.81
ROA (%)
6.47
EBITDA Margin (%)
9.99
Net Profit Margin (%)
5.07
Debt/Equity
0.27
Current Ratio
1.88
Interest Coverage
6.67
Asset Turnover
1.28
Working Capital/Sales
2.94
Core EBITDA Growth (%)
61.11
P&L
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Gross Sales | 3277.47 | 3359 | 4282.84 | 4654.79 | 8204.23 |
| Net Sales | 3277.47 | 3359 | 4282.84 | 4654.79 | 8204.23 |
| Total Income | 3286.89 | 3448 | 4447.03 | 4706.15 | 8205.24 |
| Total Expenditure | 3061.25 | 2823 | 3890.13 | 4196.62 | 7384.33 |
| Operating Profit | 225.64 | 625 | 556.9 | 509.53 | 820.91 |
| Depreciation | 27.62 | 37 | 42.5 | 44.27 | 99.25 |
| Exceptional Items | — | — | — | — | — |
| Profit Before Tax | 74.66 | 380 | 371.94 | 379.25 | 613.54 |
| Tax | 20.45 | 99 | 90.98 | 49.21 | 197.68 |
| Profit After Tax (PAT) | 54.21 | 281 | 280.96 | 330.04 | 415.86 |
| EPS (₹) | 0.89 | 4.12 | 2.9 | 1 | 1.26 |
| Dividend Payout % | — | — | — | 2.5 | — |
Balance Sheet
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Share Capital | 49.7 | 802 | 1099.84 | 1099.84 | 3299.53 |
| Reserves | 637.55 | 327 | 2126.91 | 2457.7 | 646.01 |
| Shareholders Funds | 687.25 | 1129 | 3226.75 | 3557.54 | 3945.54 |
| Total Debt | 1681.45 | 1585 | 717.91 | 569.23 | 1059.02 |
| Total Liabilities | 2900.69 | 4826 | 4905.74 | 5658.85 | 7191.4 |
| Total Assets | 2900.69 | 4826 | 4905.74 | 5658.85 | 7191.4 |
| Book Value / Share | 138.2797 | 14.0773 | 29.3384 | 32.346 | 11.9579 |
| Assets | 2900.69 | 4826 | 4905.74 | 5658.85 | 7191.4 |
Cash Flows
| Particulars | FY 2020-21 (Mar) | FY 2021-22 (Mar) | FY 2022-23 (Mar) | FY 2023-24 (Mar) | FY 2024-25 (Mar) |
|---|---|---|---|---|---|
| Operating Activities | -586.57 | 232 | -906.91 | 840.84 | -353.15 |
| Investing Activities | -164.44 | -71 | 87.1 | -608.66 | -1.04 |
| Financing Activities | 724.89 | -146 | 807.18 | -234.69 | 354.17 |
| Net Cash Flow | -26.12 | 15 | -12.63 | -2.51 | -0.02 |
JFLLIFE
₹10.85
+0%